Access & marketing scale: A favorable FDA ruling allows telehealth platforms to expand their treatment catalogs and aggressively market peptide protocols for recovery, gut health, and longevity
Prescription medications such as Mounjaro, Zepbound, Wegovy, and Ozempic, on the other hand, require FDA approval for prescriptions
Timing purchases around promotional periods can reduce costs significantly
Retatrutide vs Orforglipron vs PlexusDx (2026): Pipeline GLP-1s, Real-World Options Retatrutide (Lilly's investigational triple agonist) and orforglipron (Lilly's oral non-peptide GLP-1) are the two big pipeline stories in 2026 but neither is FDA-approved yet
Although these agents are widely used during AAS post-cycle therapy, there are no controlled data in AAS users regarding CV outcomes
: :